INFORMATION SOURCED
25
Geographical Analysis
RELATED REPORTS
RELATED REPORTS
SR . NO . REPORT TITLE PUBLISHED DATE
1
BIOSIMILARS MARKET By Product ( Recombinant Non-Glycosylated Proteins ( Insulin , Filgrastim , Interferons , rHGH ), Glycosylated ( Monoclonal Antibodies , EPO ), Peptides ( Glucagon , Calcitonin )) & Application ( Oncology , Blood Disorders ) - Trends & Global Forecast to 2020
July 2015
2
PROTEIN ENGINEERING MARKET By Technology ( Rational Protein Design , Irrational Protein Design ), Product ( Instrument , Services ), Protein Type ( Monoclonal Antibodies , Interferon , Growth Hormone ), End User ( Academics Institutes , CROs ) - Forecasts to 2020
March 2015
Human Insulin Market – Forecasts to 2020
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED This research report categorizes the global human insulin market into the following segments :
HUMAN INSULIN MARKET , BY REGION
� North America U . S .
• Canada
� Europe Germany France U . K .
• Rest of Europe ( RoE )
� Asia-Pacific
• Japan China India
• Rest of Asia-Pacific ( RoAPAC )
� Rest of the World ( RoW )
•
•
HUMAN INSULIN MARKET , BY APPLICATION
� Type I Diabetes
� Type II Diabetes
HUMAN INSULIN DELIVERY DEVICES
MARKET , BY TYPE Human Insulin Syringes
� Human Insulin Pens
• Reusable Pens
• Disposable Pens
� Human Insulin Pen Needles
• Safety Pen Needles
• Standard Pen Needles
HUMAN INSULIN MARKET , BY PRODUCT Drugs
� Delivery Devices
HUMAN INSULIN DRUGS MARKET , BY TYPE
� Human Insulin Biologics
• Short Acting
• Intermediate Acting
• Premixed
� Insulin Analogs and Biosimilars
• Long Acting
• Premixed
• Rapid Acting
HUMAN INSULIN DRUGS MARKET , BY BRAND
� Human Insulin Biologics
• Humulin
• Insuman
� Insulin Analogs and Biosimilars
• Lantus
• NovoRapid / NovoLog
• Humalog
• Actrapid , Insulatard , and Mixtard
• Others
Human Insulin Market – Forecasts to 2020
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
This research study involves the extensive usage of secondary sources , directories , and databases ( such as Hoovers , Bloomberg Business , Factiva , and Avention ), to identify and collect information useful for this technical , market-oriented , and financial study of the global human insulin market . In-depth interviews were conducted with various primary respondents , including key-industry participants , subject-matter experts ( SMEs ), C-level executives of key market players , and industry consultants , among other experts , to obtain and verify critical qualitative and quantitative information and to assess future market prospects . The following figure shows the market research methodology applied in making this report .
FIGURE 1 RESEARCH DESIGN
HISTORICAL DATA INSULIN MARKET
FOR THE HUMAN
INFLUENCING FACTORS ( Market Trends and Dynamics )
MARKET SHARE ANALYSIS
MARKET DRIVERS :
GEOGRAPHIC ANALYSIS
• Growing diabetes patient population
• Increasing population exposure to key risk factors
• Rising market demand for human insulin analogs
• Technological advancements
• Favorable medical reimbursements
MARKET RESTRAINTS :
Human Insulin Market – Forecasts to 2020
2.2 MARKET SIZE ESTIMATION
The top-down approach was followed to estimate and validate the size of the global human insulin market and other dependent submarkets . The key players in the market were identified through secondary research , and their market shares in the respective regions were determined through primary and secondary research . This entire research methodology includes the study of the annual and quarterly financial reports of the top market players , as well as interviews with industry experts ( such as CEOs , VPs , directors , and marketing executives ) for key insights ( both quantitative and qualitative ) on the global human insulin market . All percentage shares , splits , and breakdowns were determined by using secondary sources , and verified through primary sources . All the possible parameters that affect the markets covered in this research study have been accounted for , viewed in extensive detail , verified through primary research , and analyzed to get the final quantitative and qualitative data . This data was consolidated and added with detailed inputs and analysis from MarketsandMarkets , and presented in this report .
COMPETITIVE LANDSCAPE
REGIONAL USAGE PATTERN
MARKET OPPORTUNITIES :
2.2.1 BOTTOM-UP APPROACH
• Growing market penetration of key players in emerging markets
• Expected patent expiry of key human insulin drugs
1.3.2 YEARS CONSIDERED FOR THE STUDY
2015e – 2020p
• Stringent regulatory requirements for product approvals
MARKET CHALLENGES :
• High product manufacturing costs
• NEW PRODUCT LAUNCHES : About 11 new product launches over the last three years
The bottom-up approach was employed to arrive at the overall size of the global human insulin market from the revenues of the key players and their shares in the market . Calculations based on the revenues of the key players identified in the market led to the overall market size .
validate the market segment revenues obtained .
• GEOGRAPHIC EXPANSIONS : About 8 major geographic expansions over the last three years
2013
2014
2015e
FORECAST PERIOD ( 2015 – 2020 )
HISTORICAL DATA OF THE MARKET
IMPACT ANALYSIS OF
MARKET TRENDS number of units sold for human insulin delivery devices as well as annual consumption of human insulin drugs and their average selling price in the respective regions ; this was used to implement the bottom-up approach . The bottom-up approach was also implemented for data extracted from secondary research to
HUMAN INSULIN MARKET :
• By Product Type
• By Drug Type
• By Drug Brand
• By Delivery Devices
• By Application
• By Region
Global Market Value
Summation of A x B of All Regions
Average Selling Price ( ASP ) Per Region for Specific Human Insulin Products ( B )
Regional Split to the Number of Units
Sold ( A )
ARRIVE AT THE MARKET SIZE , SHARE , AND CAGR FOR THE HUMAN INSULIN MARKET
North America ( Total Number of Human Insulin Product Units Sold x ASP ) + Europe ( Total Number of Human Insulin Product Units Sold x ASP ) +………………………..
Total Market Size ( USD Million ) =
PRIMARY SOURCES :
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
After arriving at the overall market size from the market size estimation process explained above , the total market was split into several segments and subsegments . In order to complete the overall market engineering process and to arrive at the exact statistics for all the segments and subsegments , the data triangulation and market breakdown procedure was employed , wherever applicable . The data was triangulated by studying various factors and trends from both the demand and supply sides . Along with this , the market was validated using a top-down approach .
FIGURE 4 DATA TRIANGULATION
PRIMARY SOURCES
INTERVIEWS WITH :
• Human Insulin Drug / Delivery
• Research Institutes , Diabetologists , and Physicians
• Chief Information Officers
• Purchase Managers in Healthcare Provider
DEMAND SIDE
Device Manufacturers
For the calculation of the global market size , individual segmental revenue was calculated based on the
FIGURE 2 BOTTOM-UP APPROACH
Human Insulin Market – Forecasts to 2020
HISTORICAL YEAR BASE YEAR
ESTIMATED YEAR FORECAST PERIOD
© MarketsandMarkets
18
Number of Human Insulin Products Sold , Globally
Demand- and Supply-side Experts
SECONDARY SOURCES : Annual Reports , Presentations , Press Releases , Journals , Paid Databases , and MarketsandMarkets Repository
Organizations
INTERVIEWS WITH :
• Presidents , CEOs , Vice Presidents , Directors , General Managers , Head of Human Insulin Business Segment , and Senior Managers
• Product / Sales / Marketing / Business Development / Client Portfolio Managers or Specialists
• Distributors / Suppliers / Chann el Partners and Business Intelligence Consultants
SUPPLY SIDE
PRIMARY SOURCES
MnM KNOW *
DATA TRIANGULATION
SECONDARY SOURCES
Annual Reports , Presentations , Websites and Press Releases of Top Players , News Articles , Journals , and Paid Databases
20
Key Players Competitive Landscape
SECONDARY SOURCES
• American Diabetes Association ( ADA )
• American Association of Endocrinology ( AAE )
• The World Bank
Market Size ( 2015 )
• World Health Organization ( WHO )
© MarketsandMarkets
© MarketsandMarkets
Porter ’ s Five Force Analysis
Opportunities and Challenges
Market Share ( 2014 )
• Organization for Economic Cooperation and Development ( OECD )
• The U . S . Census Bureau
Drivers and Restraints
MnM KNOW * stands for ‘ MarketsandMarkets Knowledge Asset Management ' framework . In this context , it stands for the existing market research knowledge repository of over 5,000 granular markets , our flagship competitive intelligence and market research platform " RT ", subject-matter experts , and independent consultants . MnM KNOW acts as an independent source that helps us validate information gathered from primary and secondary sources .
© MarketsandMarkets
23 sales @ marketsandmarkets . com www . marketsandmarkets . com
26